Home › Vertex Pharmaceuticals Incorporated (VRTX) Earns Outperform Rating from Leerink Swann
 

Keywords :   


Vertex Pharmaceuticals Incorporated (VRTX) Earns Outperform Rating from Leerink Swann

2016-04-10 19:10:39| Biotech - Topix.net

A number of other research firms also recently weighed in on VRTX. Piper Jaffray reaffirmed an overweight rating and set a $180.00 price target on shares of Vertex Pharmaceuticals in a research note on Tuesday, January 5th.

Tags: rating incorporated pharmaceuticals earns

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
27.06Eastern North Pacific Tropical Weather Outlook
27.06Atlantic Tropical Weather Outlook
27.06Texas & Southwestern Cattle Raisers Association concludes 2024 summer meeting
27.06CCA secures funding for wolf compensation in revised budget
27.06Kimberly-Clark Could Close U.K. Plant
27.06MU Extension to host 3 feedlot educational events this summer
27.06Whats your marketing plan for beef-on-dairy calves?
27.06Sunn hemp can boost summer pastures
More »